GBT2104-131 A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease (SCD) Experiencing Vaso-occlusive Crisis (VOCs)
Administered By
Awarded By
Contributors
- Telen, Marilyn Jo Principal Investigator
Start/End
- June 4, 2021 - May 31, 2024